Publications by authors named "Johanne Pereira Ribeiro"

Article Synopsis
  • The study systematically reviews the effectiveness of medications for treating co-occurring mental health disorders in people with borderline personality disorder (BPD), using updated data from 22 trials.* -
  • Findings show very-low-certainty and low-certainty evidence for antipsychotics and anticonvulsants affecting depressive and anxious symptoms, but no significant benefit from antidepressants.* -
  • Overall, the evidence does not endorse the use of medications for co-occurring issues in BPD patients, and suggests that medications should be used carefully in these cases.*
View Article and Find Full Text PDF

Background: Systematic reviews and data synthesis of randomised clinical trials play a crucial role in clinical practice, research, and health policy. Trial sequential analysis can be used in systematic reviews to control type I and type II errors, but methodological errors including lack of protocols and transparency are cause for concern. We assessed the reporting of trial sequential analysis.

View Article and Find Full Text PDF

Background: Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed and treated psychiatric disorders in childhood. Typically, children and adolescents with ADHD find it difficult to pay attention and they are hyperactive and impulsive. Methylphenidate is the psychostimulant most often prescribed, but the evidence on benefits and harms is uncertain.

View Article and Find Full Text PDF

Background: Among people with a diagnosis of borderline personality disorder (BPD) who are engaged in clinical care, prescription rates of psychotropic medications are high, despite the fact that medication use is off-label as a treatment for BPD. Nevertheless, people with BPD often receive several psychotropic drugs at a time for sustained periods.

Objectives: To assess the effects of pharmacological treatment for people with BPD.

View Article and Find Full Text PDF

Current evidence suggests that individuals with borderline personality disorder (BPD) are likely to benefit from specialized, or BPD-specific, treatments. Dialectical behavior therapy (DBT) and mentalization-based treatment (MBT) are currently the most intensively researched BPD treatments. Reviewing the current research, this paper highlights similarities and differences between the two treatments, and discusses possible ways they could complement each other.

View Article and Find Full Text PDF

Background: A recently updated Cochrane review supports the efficacy of psychotherapy for borderline personality disorder (BPD).

Aims: To evaluate the effects of standalone and add-on psychotherapeutic treatments more concisely.

Method: We applied the same methods as the 2020 Cochrane review, but focused on adult samples and comparisons of active treatments and unspecific control conditions.

View Article and Find Full Text PDF

Background: Studies have pointed to a complicated and mutual relationship between attention deficit hyperactivity disorder (ADHD) and attachment. In an observational follow-up study conducted in 2015 60 children from 7 years to 12 years recently diagnosed with ADHD were included and assessed according to attachment representation showing 85% of the children to be insecurely attached.

Aim: The aim of this study was to investigate the stability of this remarkably high frequency of insecure attachment in the same cohort of children.

View Article and Find Full Text PDF

: Attention deficit hyperactivity disorder is the most common childhood psychiatric disorder. Current treatment strategies do not provide a convincing improvement on overall functioning, and further, reciprocity between ADHD and attachment has been suggested. This suggests that we do not fully comprehend the mechanisms of the disorder.

View Article and Find Full Text PDF

Objective: Attention deficit hyperactivity disorder (ADHD) is a common psychiatric disorder diagnosed in increasing proportions of children and adolescents. The psychostimulant methylphenidate has been considered the first-line pharmacological treatment for children and adolescents with ADHD for more than 60 years. Considering recent publications on methylphenidate for ADHD, we here give an overview of its effects in children and adolescents with ADHD, elicited by a well-disputed Cochrane review and narratively synthesise the evidence in the field.

View Article and Find Full Text PDF

Introduction: The heterogeneity in people with borderline personality disorder (BPD) and the range of specialised psychotherapies means that people with certain BPD characteristics might benefit more or less from different types of psychotherapy. Identifying moderating characteristics of individuals is a key to refine and tailor standard treatments so they match the specificities of the individual participant. The objective of this is to improve the quality of care and the individual outcomes.

View Article and Find Full Text PDF